Literature DB >> 15972639

Homeostatic role of interferons conferred by inhibition of IL-1-mediated inflammation and tissue destruction.

Xiaoyu Hu1, Hao H Ho, Olivia Lou, Chisa Hidaka, Lionel B Ivashkiv.   

Abstract

In addition to their well known immune and proinflammatory activities, IFNs possess homeostatic functions that limit inflammation and tissue destruction in a variety of conditions such as arthritis, osteolysis, and multiple sclerosis. The mechanisms underlying the homeostatic actions of IFNs are not well understood. We report here that both type I and type II IFNs (IFN-alpha, IFN-beta, and IFN-gamma, respectively) suppressed a broad range of proinflammatory and tissue-destructive activities of IL-1, including induction of inflammatory mediators, production of matrix metalloproteinases, macrophage tissue invasion, and cartilage degradation. IFN-alpha attenuated IL-1-mediated cell recruitment in vivo. IFNs completely suppressed the activation of IL-1 signal transduction pathways in macrophages. The mechanism of IFN-mediated inhibition of IL-1 action and signaling was modulation of IL-1R expression, which was also observed in vivo. IFN-gamma-mediated down-regulation of IL-1R type I expression was dependent on Stat1, a transcription factor typically considered to be a key mediator of macrophage activation by IFNs. These results identify cellular and molecular mechanisms that contribute to the homeostatic role of IFNs in limiting inflammation and associated tissue destruction.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15972639     DOI: 10.4049/jimmunol.175.1.131

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity.

Authors:  Emily Pierson; Sarah B Simmons; Luca Castelli; Joan M Goverman
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression.

Authors:  Michael M Reily; Carlos Pantoja; Xiaoyu Hu; Yurii Chinenov; Inez Rogatsky
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

3.  Interleukin-1 in monocyte activation phenotypes in systemic juvenile idiopathic arthritis: Observations from a clinical trial of rilonacept, an interleukin-1 inhibitor.

Authors:  Yujuan Zhang; Saloni Gupta; Alexandra Ilstad-Minnihan; Sashi Ayyangar; Arielle D Hay; Virginia Pascual; Norman T Ilowite; Claudia Macaubas; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2018-06-19       Impact factor: 3.969

4.  The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness.

Authors:  Keith A Sikora; Ndate Fall; Sherry Thornton; Alexei A Grom
Journal:  Arthritis Rheum       Date:  2012-11

5.  Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.

Authors:  R Ahmad; H Y Qureshi; M El Mabrouk; J Sylvester; M Ahmad; M Zafarullah
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

6.  Innate and adaptive interferons suppress IL-1α and IL-1β production by distinct pulmonary myeloid subsets during Mycobacterium tuberculosis infection.

Authors:  Katrin D Mayer-Barber; Bruno B Andrade; Daniel L Barber; Sara Hieny; Carl G Feng; Patricia Caspar; Sandy Oland; Siamon Gordon; Alan Sher
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

Review 7.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

8.  Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

Authors:  Charlotte E Page; Shaun Smale; Sara M Carty; Nicholas Amos; Sarah N Lauder; Rhian M Goodfellow; Peter J Richards; Simon A Jones; Nicholas Topley; Anwen S Williams
Journal:  Arthritis Res Ther       Date:  2010-03-22       Impact factor: 5.156

9.  Altered signaling in systemic juvenile idiopathic arthritis monocytes.

Authors:  Claudia Macaubas; Elizabeth Wong; Yujuan Zhang; Khoa D Nguyen; Justin Lee; Diana Milojevic; Susan Shenoi; Anne M Stevens; Norman Ilowite; Vivian Saper; Tzielan Lee; Elizabeth D Mellins
Journal:  Clin Immunol       Date:  2015-12-31       Impact factor: 3.969

10.  IFN-gamma and STAT1 arrest monocyte migration and modulate RAC/CDC42 pathways.

Authors:  Yang Hu; Xiaoyu Hu; Laurence Boumsell; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.